Drugs / DLI
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03662087 | Oct 2018 → Oct 2021 | — | Nanfang Hospital, Southern Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DLI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03662087 ↗ |
| Modality | Cell therapy | “Donor lymphocyte infusion” NCT03662087 ↗ |